Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05835102Recruiting

Influence of Nutritional Indices on the Prognosis of Patients With SARS-CoV-2 Infection

Role: lead

NCT06328517Recruiting

The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive Models

Role: lead

NCT05635279Completed

Effect of Nutritional Indices on the Prognosis of HCC Patients

Role: lead

NCT07031843Recruiting

Exploration of a Novel Prognostic Prediction Model for Liver Cirrhosis

Role: lead

All 4 trials loaded